Should I buy or sell Balchem stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BCPC shares. View BCPC analyst ratings or view top-rated stocks .

What is Balchem's stock price target for 2024?

1 Wall Street analysts have issued twelve-month target prices for Balchem's stock. Their BCPC share price targets range from $135.00 to $135.00. On average, they anticipate the company's stock price to reach $135.00 in the next twelve months. This suggests a possible upside of 8.1% from the stock's current price. View analysts price targets for BCPC or view top-rated stocks among Wall Street analysts .

How have BCPC shares performed in 2023?

Balchem's stock was trading at $122.11 at the start of the year. Since then, BCPC shares have increased by 2.3% and is now trading at $124.94. View the best growth stocks for 2023 here .

Are investors shorting Balchem?

Balchem saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 256,800 shares, an increase of 19.9% from the October 31st total of 214,200 shares. Based on an average daily trading volume, of 85,200 shares, the short-interest ratio is presently 3.0 days. Approximately 0.8% of the company's stock are short sold. View Balchem's Short Interest .

When is Balchem's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 23rd 2024. View our BCPC earnings forecast .

How were Balchem's earnings last quarter?

Balchem Co. (NASDAQ:BCPC) announced its quarterly earnings results on Friday, October, 27th. The basic materials company reported $0.90 EPS for the quarter, missing analysts' consensus estimates of $0.91 by $0.01. The basic materials company earned $229.95 million during the quarter, compared to the consensus estimate of $238.47 million. Balchem had a trailing twelve-month return on equity of 10.48% and a net margin of 11.15%.

How often does Balchem pay dividends? What is the dividend yield for Balchem?

Balchem declared an annual dividend on Thursday, October 5th. Investors of record on Friday, December 29th will be given a dividend of $0.398 per share on Tuesday, January 16th. This represents a yield of 0.32%. The ex-dividend date is Thursday, December 28th. Read our dividend analysis for BCPC .

Is Balchem a good dividend stock?

Balchem (NASDAQ:BCPC) pays an annual dividend of $0.71 per share and currently has a dividend yield of 0.58%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 22.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BCPC will have a dividend payout ratio of 18.83% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for BCPC .

What ETFs hold Balchem's stock?

ETFs with the largest weight of Balchem (NASDAQ:BCPC) stock in their portfolio include Invesco S&P SmallCap Materials ETF (PSCM) , Subversive Food Security ETF (KCAL) , VanEck Future of Food ETF (YUMY) , iShares S&P Small-Cap 600 Growth ETF (IJT) , Vanguard S&P Small-Cap 600 Growth ETF (VIOG) , SPDR S&P 600 Small Cap Growth ETF (SLYG) , VanEck Agribusiness ETF (MOO) and SPDR S&P SmallCap 600 ESG ETF (ESIX) .

What is Dino A. Rossi's approval rating as Balchem's CEO?

25 employees have rated Balchem Chief Executive Officer Dino A. Rossi on Glassdoor.com . Dino A. Rossi has an approval rating of 85% among the company's employees. 62.0% of employees surveyed would recommend working at Balchem to a friend.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL) , CVS Health (CVS) , AbbVie (ABBV) , Johnson & Johnson (JNJ) , Lowe's Companies (LOW) , Altria Group (MO) , NVIDIA (NVDA) , AT&T (T) , Analog Devices (ADI) and Bristol-Myers Squibb (BMY) .

Who are Balchem's major shareholders?

Balchem's stock is owned by a number of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (3.34%), Schroder Investment Management Group (1.74%), Morgan Stanley (1.63%), Clearbridge Investments LLC (1.61%), Ameriprise Financial Inc. (1.25%) and Northern Trust Corp (1.24%). Insiders that own company stock include David B Fischer , Gunsteren Job Leonard Van , Michael Robert Sestrick and William A Backus . View institutional ownership trends .

How do I buy shares of Balchem?

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Does Balchem have any subsidiaries?

The following companies are subsidiares of Balchem: Aberco Inc., Aberco Inc., Albion Laboratories Inc., Albion Laboratories Inc., BCP Ingredients Inc., Balchem BV, Balchem Italia Srl, Balchem Ltd., Balchem NV, Balchem Pte Ltd., Balchem Pty Ltd., Balchem Sdn Bhd, Bioscreen technologies, Chemogas Holding NV, Chol-Mix Kft, Innovative Food Processors, SensoryEffects, SensoryEffects Cereal Systems Inc., SensoryEffects Inc., Stereo Gas Philippines Inc., and Zumbro River Brand Inc.. Read More

Balchem Stock Price, News & Analysis (NASDAQ:BCPC)

$124.94

+2.23 (+1.82%)

(As of 03:57 PM ET)

Compare

Today's Range: $123.30
▼
$125.01
50-Day Range: $115.08
▼
$130.30
52-Week Range: $110.74
▼
$143.68

Volume: 58,773 shs
Average Volume: 90,447 shs
Market Capitalization: $4.03 billion

P/E Ratio: 39.17
Dividend Yield: 0.57%
Price Target: $135.00

Balchem MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 8.1% Upside
$135.00 Price Target
Short Interest: Healthy
0.80% of Float Sold Short
Dividend Strength: Strong
Based on Four Factors
Sustainability: -1.54
Upright™ Environmental Score
News Sentiment: 0.76
Based on 3 Articles This Week
Insider Trading: Selling Shares
$499,966 Sold Last Quarter
Proj. Earnings Growth: 10.56%
From $3.41 to $3.77 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.32 out of 5 stars

Basic Materials Sector

30th out of 165 stocks

Chemicals & Allied Products Industry

4th out of 15 stocks

1.5

Analyst's Opinion

Consensus Rating
Balchem has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $135.00, Balchem has a forecasted upside of 8.1% from its current price of $124.94.
Amount of Analyst Coverage
Balchem has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
0.80% of the float of Balchem has been sold short.
Short Interest Ratio / Days to Cover
Balchem has a short interest ratio ("days to cover") of 3, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Balchem has recently increased by 19.89%, indicating that investor sentiment is decreasing significantly.

3.3

Dividend Strength

Dividend Yield
Balchem has a dividend yield of 0.58%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
Balchem has been increasing its dividend for 14 years.
Dividend Coverage
The dividend payout ratio of Balchem is 22.26%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Balchem will have a dividend payout ratio of 18.83% next year. This indicates that Balchem will be able to sustain or increase its dividend.

2.3

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Balchem has received a 6.99% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is mostly driven by its "Whey proteins", "Soy proteins", and "Food preservatives" products. See details.
Environmental Sustainability
The Environmental Impact score for Balchem is -1.54.

2.6

News and Social Media Coverage

News Sentiment
Balchem has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.29 average news sentiment score of Basic Materials companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Balchem this week, compared to 2 articles on an average week.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Balchem insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $499,966.00 in company stock.
Percentage Held by Insiders
Only 1.77% of the stock of Balchem is held by insiders.
Percentage Held by Institutions
87.91% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Balchem are expected to grow by 10.56% in the coming year, from $3.41 to $3.77 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Balchem is 39.17, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 117.64.
Price to Earnings Ratio vs. Sector
The P/E ratio of Balchem is 39.17, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 88.12.
Price to Earnings Growth Ratio
Balchem has a PEG Ratio of 4.52. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
Balchem has a P/B Ratio of 3.93. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Balchem Stock (NASDAQ:BCPC)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; single use canisters for sterilizing re-usable devices; and ammonia. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in Montvale, New Jersey.

BCPC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BCPC Stock News Headlines

November 23, 2023 | finance.yahoo.com

Balchem Corporation (NASDAQ:BCPC) is a favorite amongst institutional investors who own 89%

November 9, 2023 | morningstar.com

Balchem Corp BCPC

November 29, 2023 | Tomorrow Investor (Ad)

The Only Practical Solution to the World’s Looming Energy Crisis

There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!

October 30, 2023 | gurufocus.com

The Balchem Corp (BCPC) Company: A Short SWOT Analysis

October 29, 2023 | finance.yahoo.com

Balchem Corporation (NASDAQ:BCPC) Q3 2023 Earnings Call Transcript

October 27, 2023 | seekingalpha.com

Balchem Q3: A Solid Performer Is Seeing A Soft 2023

October 27, 2023 | seekingalpha.com

Balchem Corporation 2023 Q3 - Results - Earnings Call Presentation

October 27, 2023 | markets.businessinsider.com

Here's what Wall Street expects from Balchem's earnings

November 29, 2023 | Tomorrow Investor (Ad)

The Only Practical Solution to the World’s Looming Energy Crisis

There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!

October 27, 2023 | gurufocus.com

Balchem Corp (BCPC) Reports Q3 2023 Sales of $229.9 Million and Net Earnings of $29.1 Million

October 27, 2023 | finance.yahoo.com

Balchem Corporation Reports Third Quarter Sales of $229.9 Million, with Net Earnings of $29.1 Million, GAAP EPS of $0.90, and Adjusted EPS of $1.04

October 26, 2023 | benzinga.com

Earnings Outlook For Balchem

October 26, 2023 | msn.com

Balchem Q3 2023 Earnings Preview

October 21, 2023 | finance.yahoo.com

The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

October 13, 2023 | finance.yahoo.com

Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 27, 2023

October 4, 2023 | finance.yahoo.com

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

September 19, 2023 | msn.com

Do Options Traders Know Something About Balchem (BCPC) Stock We Don't?

September 14, 2023 | fool.com

Balchem (NASDAQ: BCPC)

September 3, 2023 | finance.yahoo.com

Balchem Corporation's (NASDAQ:BCPC) Has Performed Well But Fundamentals Look Varied: Is There A Clear Direction For The Stock?

July 31, 2023 | seekingalpha.com

Balchem: Still Neutral Considering Both Q2 Results And Outlook

July 29, 2023 | finance.yahoo.com

Balchem Corporation (NASDAQ:BCPC) Q2 2023 Earnings Call Transcript

July 29, 2023 | finance.yahoo.com

Q2 2023 Balchem Corp Earnings Call

July 28, 2023 | finance.yahoo.com

Balchem Corporation Reports Second Quarter Sales of $231.3 Million, with Net Earnings of $30.1 Million, GAAP EPS of $0.93, and Adjusted EPS of $1.06

July 22, 2023 | finance.yahoo.com

Those who invested in Balchem (NASDAQ:BCPC) three years ago are up 36%

July 14, 2023 | finance.yahoo.com

Balchem Corporation Announces Quarterly Conference Call for Second Quarter Financial Results on July 28, 2023

June 6, 2023 | finance.yahoo.com

Balchem Corporation to Present at the Sidoti June 2023 Virtual Small-Cap Conference June 15, 2023

June 5, 2023 | msn.com

HC Wainwright & Co. Maintains Balchem (BCPC) Buy Recommendation

See More Headlines

Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/27/2023
Today: 11/29/2023
Ex-Dividend for 1/16 Dividend: 12/28/2023
Fiscal Year End: 12/31/2023
Dividend Payable: 1/16/2024
Next Earnings (Estimated): 2/23/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Chemicals & allied products
Sub-Industry: Specialty Chemicals
Sector: Basic Materials
Current Symbol: NASDAQ:BCPC
CUSIP: 05766520
CIK: 9326
Web: www.balchem.com
Phone: (845) 326-5600
Fax: 845-326-5717
Employees: 1,340
Year Founded: 1967

Price Target and Rating

Average Stock Price Target: $135.00
High Stock Price Target: $135.00
Low Stock Price Target: $135.00
Potential Upside/Downside: +10.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): $3.19
Trailing P/E Ratio: 38.47
Forward P/E Ratio: 35.99
P/E Growth: 4.52
Net Income: $105.37 million
Net Margins: 11.15%
Pretax Margin: 14.01%
Return on Equity: 10.48%
Return on Assets: 6.38%

Debt

Debt-to-Equity Ratio: 0.39
Current Ratio: 3.16
Quick Ratio: 2.08

Sales & Book Value

Annual Sales: $942.36 million
Price / Sales: 4.20
Cash Flow: $4.87 per share
Price / Cash Flow: 25.19
Book Value: $31.80 per share
Price / Book: 3.86

Miscellaneous

Outstanding Shares: 32,240,000
Free Float: 31,670,000
Market Cap: $3.96 billion
Optionable: Optionable
Beta: 0.68

Social Links

Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

Mr. Theodore L. Harris (Age 58)
Chairman, CEO & President
Comp: $2.33M
Mr. Carl Martin Bengtsson (Age 45)
Executive VP, CFO & Treasurer
Comp: $864.13k
Ms. Hatsuki Miyata (Age 47)
Executive VP, General Counsel & Secretary
Comp: $618.21k
Mr. Jonathan H. Griffin (Age 47)
Senior VP and GM of Animal Nutrition & Health
Comp: $624.01k
Mr. Martin Luther Reid (Age 55)
Senior VP & Chief Supply Chain Officer
Comp: $672.26k
Mr. William A. Backus CPA (Age 57)
VP & CAO
Comp: $560.79k
Mr. Michael R. Sestrick Ph.D. (Age 59)
Senior VP & CTO
Mr. Brent Tignor (Age 45)
Senior VP & Chief Human Resources Officer
Mr. Frederic Boned (Age 45)
Senior VP and GM of Human Nutrition & Health
Mr. Job L. van Gunsteren (Age 47)
Senior VP & GM of Specialty Products

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

BCPC Stock Analysis - Frequently Asked Questions

Should I buy or sell Balchem stock right now?: 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Balchem in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BCPC shares.
View BCPC analyst ratings or view top-rated stocks.
What is Balchem's stock price target for 2024?: 1 Wall Street analysts have issued twelve-month target prices for Balchem's stock. Their BCPC share price targets range from $135.00 to $135.00. On average, they anticipate the company's stock price to reach $135.00 in the next twelve months. This suggests a possible upside of 8.1% from the stock's current price.
View analysts price targets for BCPC or view top-rated stocks among Wall Street analysts.
How have BCPC shares performed in 2023?: Balchem's stock was trading at $122.11 at the start of the year. Since then, BCPC shares have increased by 2.3% and is now trading at $124.94.
View the best growth stocks for 2023 here.
Are investors shorting Balchem?: Balchem saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 256,800 shares, an increase of 19.9% from the October 31st total of 214,200 shares. Based on an average daily trading volume, of 85,200 shares, the short-interest ratio is presently 3.0 days. Approximately 0.8% of the company's stock are short sold.
View Balchem's Short Interest.
When is Balchem's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Friday, February 23rd 2024.
View our BCPC earnings forecast.
How were Balchem's earnings last quarter?: Balchem Co. (NASDAQ:BCPC) announced its quarterly earnings results on Friday, October, 27th. The basic materials company reported $0.90 EPS for the quarter, missing analysts' consensus estimates of $0.91 by $0.01. The basic materials company earned $229.95 million during the quarter, compared to the consensus estimate of $238.47 million. Balchem had a trailing twelve-month return on equity of 10.48% and a net margin of 11.15%.
How often does Balchem pay dividends? What is the dividend yield for Balchem?: Balchem declared an annual dividend on Thursday, October 5th. Investors of record on Friday, December 29th will be given a dividend of $0.398 per share on Tuesday, January 16th. This represents a yield of 0.32%. The ex-dividend date is Thursday, December 28th.
Read our dividend analysis for BCPC.
Is Balchem a good dividend stock?: Balchem (NASDAQ:BCPC) pays an annual dividend of $0.71 per share and currently has a dividend yield of 0.58%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 22.26%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, BCPC will have a dividend payout ratio of 18.83% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for BCPC.

What ETFs hold Balchem's stock?: ETFs with the largest weight of Balchem (NASDAQ:BCPC) stock in their portfolio include Invesco S&P SmallCap Materials ETF (PSCM), Subversive Food Security ETF (KCAL), VanEck Future of Food ETF (YUMY), iShares S&P Small-Cap 600 Growth ETF (IJT), Vanguard S&P Small-Cap 600 Growth ETF (VIOG), SPDR S&P 600 Small Cap Growth ETF (SLYG), VanEck Agribusiness ETF (MOO) and SPDR S&P SmallCap 600 ESG ETF (ESIX).
What is Dino A. Rossi's approval rating as Balchem's CEO?: 25 employees have rated Balchem Chief Executive Officer Dino A. Rossi on Glassdoor.com. Dino A. Rossi has an approval rating of 85% among the company's employees. 62.0% of employees surveyed would recommend working at Balchem to a friend.
What other stocks do shareholders of Balchem own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Balchem investors own include Ecolab (ECL), CVS Health (CVS), AbbVie (ABBV), Johnson & Johnson (JNJ), Lowe's Companies (LOW), Altria Group (MO), NVIDIA (NVDA), AT&T (T), Analog Devices (ADI) and Bristol-Myers Squibb (BMY).
Who are Balchem's major shareholders?: Balchem's stock is owned by a number of retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (3.34%), Schroder Investment Management Group (1.74%), Morgan Stanley (1.63%), Clearbridge Investments LLC (1.61%), Ameriprise Financial Inc. (1.25%) and Northern Trust Corp (1.24%). Insiders that own company stock include David B Fischer, Gunsteren Job Leonard Van, Michael Robert Sestrick and William A Backus.
View institutional ownership trends.
How do I buy shares of Balchem?: Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
Does Balchem have any subsidiaries?: The following companies are subsidiares of Balchem: Aberco Inc., Aberco Inc., Albion Laboratories Inc., Albion Laboratories Inc., BCP Ingredients Inc., Balchem BV, Balchem Italia Srl, Balchem Ltd., Balchem NV, Balchem Pte Ltd., Balchem Pty Ltd., Balchem Sdn Bhd, Bioscreen technologies, Chemogas Holding NV, Chol-Mix Kft, Innovative Food Processors, SensoryEffects, SensoryEffects Cereal Systems Inc., SensoryEffects Inc., Stereo Gas Philippines Inc., and Zumbro River Brand Inc..
Read More

This page (NASDAQ:BCPC) was last updated on 11/29/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial